Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder

American Journal of Psychiatry

Fecha de publicación: 29 de octubre de 2020

Autores: Lara N. Coughlin, Ph.D., Paul Pfeiffer, M.D., M.S., Dara Ganoczy, M.P.H., Lewei A. Lin, M.D., M.S.

DOI: https://doi.org/10.1176/appi.ajp.2020.20040454

Background: Clinical practice guidelines recommend concurrent treatment of co-occurring depression and substance use disorders; however, the degree to which patients with substance use disorders receive guideline-concordant treatment for depression is unknown. The authors investigated the provision of guideline-concordant depression treatment to patients with and without substance use disorders in a large integrated health care system.

Enviar comentario